Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion type Assertion NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_head.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion description "[However, in males, the relatively rare heterozygous genotype GT/(GT) at -663 in the promoter and the variant homozygous genotype G/G at intron 5-5229 appeared to have inverse associations (odds ratio (OR)=0.59, confidence interval (CI): 0.34-1.02 and OR=0.48, CI: 0.24-0.99, respectively), whereas the heterozygous genotype T/C at 3'UTR-8494 had a positive association (OR=1.31, CI: 1.01-1.71) with adenoma development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_provenance.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion evidence source_evidence_literature NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_provenance.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion SIO_000772 16205694 NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_provenance.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion wasDerivedFrom befree-20140225 NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_provenance.
- NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_assertion wasGeneratedBy ECO_0000203 NP721277.RAHdquA2iESKwHDUwGcD4ZYDhPzYRXsGuOENwzf5vnxQ0130_provenance.